Oncology Institute Past Earnings Performance
Past criteria checks 0/6
Oncology Institute's earnings have been declining at an average annual rate of -61.6%, while the Healthcare industry saw earnings growing at 5.3% annually. Revenues have been growing at an average rate of 19.3% per year.
Key information
-61.6%
Earnings growth rate
-60.6%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 19.3% |
| Return on equity | -453.7% |
| Net Margin | -15.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
A Piece Of The Puzzle Missing From The Oncology Institute, Inc.'s (NASDAQ:TOI) 28% Share Price Climb
Jul 19
The Oncology Institute, Inc. (NASDAQ:TOI) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny
May 05Not Many Are Piling Into The Oncology Institute, Inc. (NASDAQ:TOI) Stock Yet As It Plummets 28%
Mar 21Is Oncology Institute (NASDAQ:TOI) A Risky Investment?
Mar 05The Oncology Institute, Inc. (NASDAQ:TOI) Stock Rockets 49% But Many Are Still Ignoring The Company
Nov 10The Oncology Institute swings to Q2 GAAP loss per share from year-ago profit
Aug 09Shareholders Shouldn’t Be Too Comfortable With Oncology Institute's (NASDAQ:TOI) Strong Earnings
May 18Companies Like Oncology Institute (NASDAQ:TOI) Are In A Position To Invest In Growth
Mar 16Revenue & Expenses Breakdown
How Oncology Institute makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 379 | -57 | 111 | 0 |
| 30 Jun 24 | 361 | -59 | 113 | 0 |
| 31 Mar 24 | 343 | -60 | 113 | 0 |
| 31 Dec 23 | 324 | -68 | 114 | 0 |
| 30 Sep 23 | 310 | -61 | 116 | 0 |
| 30 Jun 23 | 293 | -50 | 120 | 0 |
| 31 Mar 23 | 274 | -40 | 120 | 0 |
| 31 Dec 22 | 252 | 0 | 120 | 0 |
| 30 Sep 22 | 233 | -1 | 137 | 0 |
| 30 Jun 22 | 221 | -2 | 118 | 0 |
| 31 Mar 22 | 210 | 6 | 100 | 0 |
| 31 Dec 21 | 203 | -11 | 83 | 0 |
| 30 Sep 21 | 200 | -6 | 50 | 0 |
| 30 Jun 21 | 195 | -3 | 46 | 0 |
| 31 Mar 21 | 192 | -5 | 44 | 0 |
| 31 Dec 20 | 188 | -14 | 42 | 0 |
| 31 Dec 19 | 155 | -4 | 30 | 0 |
| 31 Dec 18 | 113 | -2 | 17 | 0 |
Quality Earnings: TOI is currently unprofitable.
Growing Profit Margin: TOI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TOI is unprofitable, and losses have increased over the past 5 years at a rate of 61.6% per year.
Accelerating Growth: Unable to compare TOI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TOI is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.3%).
Return on Equity
High ROE: TOI has a negative Return on Equity (-453.66%), as it is currently unprofitable.